A heterozygous genotype means you carry two different versions of a gene, one inherited from each biological parent. Every human has two copies of most genes (one from mom, one from dad), and when those two copies aren’t identical, that gene is heterozygous. If you’ve seen this term on a genetic test report, it simply means one copy of a particular gene has a variant that the other copy doesn’t.
How Heterozygous Differs From Homozygous
Your DNA is organized into pairs of chromosomes. For any given gene sitting at a specific location on a chromosome, you have two versions, called alleles. When both alleles are the same, the genotype is homozygous. When they differ, it’s heterozygous. A simple way to picture it: if we label two alleles as A and a, then AA and aa are homozygous genotypes while Aa is heterozygous.
This distinction matters because the combination of alleles you carry determines how a trait shows up in your body, whether that’s eye color, blood type, or susceptibility to certain diseases.
What Trait Actually Shows Up
In the simplest pattern of inheritance, one allele is dominant and the other is recessive. If you’re heterozygous for such a gene, the dominant allele dictates what you see. A classic example: if you inherit one allele for brown eyes (dominant) and one for blue eyes (recessive), your eyes will be brown. You still carry the blue-eye allele and can pass it to your children, but it stays silent in you.
Not every gene follows this straightforward rule. Two other patterns are common:
- Incomplete dominance: The heterozygous trait lands somewhere between the two homozygous versions, producing a blended result. A person who inherits one allele for curly hair and one for straight hair often ends up with wavy hair, for instance.
- Codominance: Both alleles express themselves fully at the same time, with no blending. Blood type is the textbook example. If you inherit an A allele from one parent and a B allele from the other, your blood type is AB because both antigens appear on your red blood cells.
So “heterozygous” doesn’t automatically mean a trait is hidden. The outcome depends on the relationship between the two alleles involved.
Carriers of Recessive Conditions
One of the most practical reasons people encounter the word “heterozygous” is carrier status for genetic diseases. Many serious conditions, like cystic fibrosis and sickle cell disease, are autosomal recessive. That means you need two copies of the altered gene (homozygous) to develop the condition. A person with only one altered copy (heterozygous) is called a carrier: they don’t have symptoms, but they can pass the allele to their children.
If both parents are carriers of the same recessive condition, each pregnancy has a 25% chance of producing a child who is homozygous for the altered gene and affected by the disease, a 50% chance of producing another carrier, and a 25% chance of producing a child with two typical copies. These probabilities apply independently to every pregnancy.
If you see “heterozygous” on a genetic test result, it typically means exactly this: one copy of the gene has a change, while the other copy is unaffected. A report from a clinical lab will often state the finding is heterozygous to clarify that only one of your two gene copies carries the variant.
When One Altered Copy Is Enough
For autosomal dominant conditions, a single copy of the altered gene causes the disease. Huntington’s disease is a well-known example. A person who is heterozygous, carrying one normal copy and one expanded copy, develops the same symptoms as someone who is homozygous with two expanded copies. Research published in Clinical Neurology and Neurosurgery confirmed that homozygous and heterozygous Huntington’s patients do not differ in their age of onset or motor symptoms, making it a fully dominant disease. Most other dominant conditions, however, tend to be more severe in homozygous individuals.
Heterozygote Advantage
Sometimes carrying two different alleles is better than carrying two of the same, a phenomenon called heterozygote advantage. The most famous example involves sickle cell trait. People who are heterozygous for the sickle cell gene (one normal hemoglobin allele, one sickle hemoglobin allele) generally don’t develop sickle cell disease, yet they gain significant protection against malaria. Studies show that children with sickle cell trait are 50% to 90% less likely to develop severe malaria or die from it compared to children with two normal hemoglobin copies.
The mechanism is surprisingly direct. When the malaria parasite invades a red blood cell carrying sickle hemoglobin, the cell deforms in a way that stunts parasite growth and flags the cell for removal by the immune system. The parasite also has trouble anchoring itself to blood vessel walls, which is normally how severe malaria causes organ damage.
This survival benefit explains why the sickle cell allele remains common in regions where malaria is widespread. Natural selection preserves the allele because heterozygous individuals survive better, even though homozygous individuals (with two sickle alleles) develop sickle cell disease. The same principle extends to immune system genes more broadly: people who are heterozygous for certain immune-related genes can recognize a wider range of pathogens, which may contribute to the remarkable diversity of these genes across human populations.
Compound Heterozygosity
Standard heterozygosity means one normal allele and one altered allele at the same spot in a gene. Compound heterozygosity is a more complex situation. It occurs when a person inherits two different mutations in the same gene, one from each parent, but at different locations within that gene. The result is that neither copy of the gene works properly.
This matters most for tumor suppressor genes and recessive diseases. If one parent passes along a gene with a mutation near the beginning and the other parent passes along the same gene with a mutation near the end, the child has no functional copy of that gene. In cancer genetics, compound heterozygous variants in tumor suppressor genes can eliminate the body’s ability to keep cell growth in check, potentially increasing cancer susceptibility. Genetic testing can distinguish compound heterozygosity from simple heterozygosity by mapping exactly where each variant sits within the gene.
Reading It on a Genetic Report
If you’re looking at a genetic test result and see “heterozygous,” the key question is what type of condition the gene is associated with. For a recessive condition, heterozygous typically means you’re a carrier with no symptoms but with implications for family planning. For a dominant condition, heterozygous means you have the genetic change that causes the condition. For pharmacogenomic genes (those affecting drug metabolism), heterozygous may mean you process a medication differently than average.
Reports sometimes use shorthand like “het” or write the genotype as one normal allele and one variant allele separated by a slash. The context around the result, including whether the variant is classified as pathogenic, likely pathogenic, or of uncertain significance, determines what the finding means for your health.